Who is sponsoring NCT05644028?

NCT05644028 is sponsored by University of Bergen.

What drugs are being tested in NCT05644028?

Interventions in NCT05644028: Emotion Regulation Intervention for ADHD.

What condition does NCT05644028 study?

NCT05644028 studies Attention Deficit Hyperactivity Disorder.

Is NCT05644028 still recruiting?

NCT05644028 is currently completed. Last updated 17 March 2025.

Last reviewed 2025-03-17 · How we verify

NCT05644028

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Pilot Study of a Blended Intervention Targeting Emotion Dysregulation in Adults With ADHD

Completed NA Last updated 17 March 2025

What this trial tests

NA trial testing Emotion Regulation Intervention for ADHD in Attention Deficit Hyperactivity Disorder in 16 participants. Completed in 18 April 2023.

Timeline

29 November 2022

Primary endpoint
14 March 2023

18 April 2023

Quick facts

Lead sponsor	University of Bergen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	16
Start date	29 November 2022
Primary completion	14 March 2023
Estimated completion	18 April 2023
Sites	1 location across Norway

Drugs / interventions tested

Emotion Regulation Intervention for ADHD

Conditions studied

Attention Deficit Hyperactivity Disorder — all drugs for Attention Deficit Hyperactivity Disorder →

Sponsor

University of Bergen

Who can join

18 and older, any sex, with Attention Deficit Hyperactivity Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study aims to investigate the feasibility and preliminary clinical effects of a blended psychological intervention targeting emotion dysregulation in adults with ADHD.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Blended Intervention Targeting Emotion Dysregulation in Adults With Attention-Deficit/Hyperactivity Disorder: Development and Feasibility Study.
Nordby ES, Guribye F, Schønning V, Andersen SL, et al · · 2024 · cited 5× · PMID 38231536 · DOI 10.2196/53931
Experiences of change following a blended intervention for adults with ADHD and emotion dysregulation: a qualitative interview study.
Nordby ES, Schønning V, Barnes A, Denyer H, et al · · 2025 · PMID 39833731 · DOI 10.1186/s12888-025-06476-1

Verify or expand the search:

Other recruiting trials for Attention Deficit Hyperactivity Disorder

Currently open trials in the same condition.

NCT07001475 — A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperact · Phase 1 · recruiting
NCT06847165 — Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure · NA · recruiting
NCT06325813 — ADHD PreSMA Response Inhibition Therapy · NA · recruiting
NCT06248229 — A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder · Phase 4 · recruiting
NCT06232226 — Attention Deficit Hyperactivity Disorder · NA · recruiting

Other University of Bergen trials

Trials by the same sponsor.

NCT07028450 — Effects of Proactive Call to Customers of Norsk Rikstoto (Horse Gambling Operator in Norway): A Randomized Controlled St · NA · not yet recruiting
NCT04602572 — Obesity and Oral Diseases in Adult Patients · not yet recruiting
NCT07460817 — A Brief Intervention for PTSD - BWRT · NA · enrolling by invitation
NCT06960226 — Replication Study: Reducing Pain With Focused Music Listening · NA · completed
NCT07299669 — Effects of BEMER Electromagnetic Field Intervention on Sleep, Readiness to Play and Injuries in Elite Athletes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05644028 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Bergen
Last refreshed: 17 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05644028.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing